SEC Form D · filed November 15, 2022
Hepion Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Arnold P. Lippa · Edison, NJDirectorJohn P. Cavan · Edison, NJExecJohn P. Brancaccio · Edison, NJDirectorRobert Foster · Edison, NJExec · DirectorTimothy P. Block · Edison, NJDirectorBruce Wiegand · Westport, CTDirectorAnn Lamont · Nashville, TNExec · DirectorReof Manager, LLC · Buford, GADirectorPanos Ninios · Westport, CTDirectorJingqiu Mei · skokie, ILExecGary S. Jacobs · Edison, NJDirectorPetrus P. Wijngaard · Edison, NJDirectorTodd Hobbs · Edison, NJExecJohn M. Cowell · Penn Yan, NYDirectorDennis A. Buchan · Rochester, NYDirectorVincent S. Maddi · New York, NYDirectorShawn M. Brennan · New York, NYExecJoel Kosakoff · Del Mar, CAExec · DirectorGary S. Jacobs · Edison, NJDirectorPetrus P. Wijngaard · Edison, NJDirectorTodd Hobbs · Edison, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗